Production (Stage)
Synaptogenix, Inc.
SNPX
$2.42
$0.167.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.44% | -17.78% | -45.87% | -47.63% | -46.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.63% | -18.08% | -43.96% | -50.50% | -55.10% |
| Operating Income | 12.63% | 18.08% | 43.96% | 50.50% | 55.10% |
| Income Before Tax | -168.59% | -111.45% | -1,366.71% | 60.63% | -13.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -168.59% | -111.45% | -1,366.71% | 60.63% | -13.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -168.59% | -111.45% | -1,366.71% | 60.63% | -13.11% |
| EBIT | 12.63% | 18.08% | 43.96% | 50.50% | 55.10% |
| EBITDA | 12.63% | 18.08% | 43.97% | 50.52% | 55.12% |
| EPS Basic | 73.75% | 76.25% | 71.39% | 89.39% | -141.84% |
| Normalized Basic EPS | 47.89% | 60.47% | -243.78% | 95.56% | 4.69% |
| EPS Diluted | 73.53% | 76.25% | 71.39% | 89.39% | -141.49% |
| Normalized Diluted EPS | 47.88% | 60.47% | -243.78% | 95.56% | 4.69% |
| Average Basic Shares Outstanding | 102.17% | 163.15% | 237.81% | 204.14% | 128.48% |
| Average Diluted Shares Outstanding | 102.45% | 163.15% | 237.81% | 204.14% | 128.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.39% | 0.30% | 0.90% | 1.00% | -- |